The exact treatment for PE depends on its severity and whether you need critical treatment in an emergency room setting. PE medications are usually considered before medical procedures.
The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.
8don MSN
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...
(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.
KKR's acquisition of SunFireMatrix and Consello's purchase of EHE Health are among the deals that exemplify the new trends.
Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted vacuum thrombectomy ...
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...
GlobalData on MSN1d
Penumbra reveals positive data for algorithm-assisted thrombectomy techPenumbra has developed a microprocessor with thrombus removal algorithms that, combined with audio-visual feedback, help ...
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
“These results are crucial to guiding optimal PE treatment decisions, providing strong evidence that FlowTriever may reduce clinical deterioration and the need for reintervention through more ...
Findings were presented from the international PEERLESS randomized controlled trial comparing patient outcomes after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback